Abstract
Attention-Deficit/Hyperactivity Disorder (ADHD) can persist into adulthood with a continuation of the pattern of childhood psychopathology, cognition and functioning. Adult comorbidities include substance use disorders, antisocial personality disorder, anxiety, and depression. Studies have shown that as in children, methylphenidate treatment for adults can lead to a robust, dose-dependent improvement in ADHD symptoms. Future research is needed to evaluate the safety and efficacy of long-term treatment with methylphenidate (MPH).
MeSH terms
-
Adolescent
-
Adult
-
Age Factors
-
Attention Deficit Disorder with Hyperactivity / diagnosis
-
Attention Deficit Disorder with Hyperactivity / drug therapy*
-
Attention Deficit Disorder with Hyperactivity / psychology
-
Central Nervous System Stimulants / administration & dosage*
-
Central Nervous System Stimulants / adverse effects
-
Child
-
Comorbidity
-
Dose-Response Relationship, Drug
-
Humans
-
Long-Term Care
-
Mental Disorders / diagnosis
-
Mental Disorders / drug therapy
-
Mental Disorders / psychology
-
Methylphenidate / administration & dosage*
-
Methylphenidate / adverse effects
-
Treatment Outcome
Substances
-
Central Nervous System Stimulants
-
Methylphenidate